The company, which is among the world’s top biosimilars manufacturers, remains in a wait-and-watch mode, while exploring partnerships for manufacturing in the US if required, Shaw said.
The company, which is among the world’s top biosimilars manufacturers, remains in a wait-and-watch mode, while exploring partnerships for manufacturing in the US if required, Shaw said. by Soban News (international And National News)